HealthLupin Launches Fixed-Dose Triple Combo Inhaler for COPD in India
Lupin has launched Formoflo-G MDI, a fixed-dose triple combination inhaler for chronic obstructive pulmonary disease (COPD) in India. Approved by the Drug Controller General of India, it combines Glycopyrronium Bromide, Formoterol Fumarate, and Fluticasone Propionate for managing moderate to severe COPD. The twice-daily inhaler enhances Lupin's respiratory portfolio, aiming to improve access to effective COPD therapies in India.
Hindu Business··Hyderabad